International Journal of Gynecology & Obstetrics
Volume 86 , Pages S53-S62 , July 2004

Duloxetine: a new approach for treating stress urinary incontinence

  • Kate Moore

      Affiliations

    • Corresponding Author InformationTel.: +61-2-9350-2054; fax: +61-2-9350-3951

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Duloxetine, a potent and balanced dual serotonin and norepinephrine reuptake inhibitor, is an effective and safe pharmacological therapy as shown in one phase 2 and three phase 3 placebo-controlled clinical trials involving approximately 2000 women with SUI.

PII: S0020-7292(04)00183-3

doi: 10.1016/j.ijgo.2004.05.009

International Journal of Gynecology & Obstetrics
Volume 86 , Pages S53-S62 , July 2004

Article Tools

* Image Usage & Resolution